释义 |
- References
Amides of lysergic acid are collectively known as lysergamides.[1][2][3] Lysergamides, tabulated by structure Name | R1 | R6 | R2 | R3 |
---|
LSA / LAA | H | CH3 | H | H | DAM-57 | H | CH3 | CH3 | CH3 | Ergometrine (Ergonovine) | H | CH3 | CH(CH3)CH2OH | H | Ergotamine | H | CH3 | -- | C17H18N2O4 | Methergine | H | CH3 | CH(CH2CH3)CH2OH | H | Methysergide | CH3 | CH3 | CH(CH2CH3)CH2OH | H | Amesergide | CH(CH3)2 | CH3 | C6H11 | H | LAE-32 | H | CH3 | CH2CH3 | H | LSB | H | CH3 | CH(CH3)CH2CH3 | H | LSP | H | CH3 | CH(CH2CH3)CH2CH3 | H | DAL | H | CH3 | H2C=CH-CH2 | H2C=CH-CH2 | MIPLA | H | CH3 | CH(CH3)2 | CH3 | EIPLA | H | CH3 | CH(CH3)2 | CH2CH3 | MPLA | H | CH3 | CH2CH2CH3 | CH3 | LSD / LAD | H | CH3 | CH2CH3 | CH2CH3 | ETH-LAD | H | CH2CH3 | CH2CH3 | CH2CH3 | PARGY-LAD | H | HC≡C−CH2 | CH2CH3 | CH2CH3 | AL-LAD | H | H2C=CH-CH2 | CH2CH3 | CH2CH3 | PRO-LAD | H | CH2CH2CH3 | CH2CH3 | CH2CH3 | CYP-LAD | H | C3H5 | CH2CH3 | CH2CH3 | BU-LAD | H | CH2CH2CH2CH3 | CH2CH3 | CH2CH3 | ALD-52 | COCH3 | CH3 | CH2CH3 | CH2CH3 | 1P-LSD | COCH2CH3 | CH3 | CH2CH3 | CH2CH3 | 1P-ETH-LAD | COCH2CH3 | CH2CH3 | CH2CH3 | CH2CH3 | MLD-41 | CH3 | CH3 | CH2CH3 | CH2CH3 | LSM-775 | H | CH3 | CH2CH2-O-CH2CH2 | LPD-824 | H | CH3 | CH2CH2CH2CH2 | LSD-Pip | H | CH3 | CH2CH2CH2CH2CH2 | LA-SS-Az | H | CH3 | CH2(CHCH3)2CH2 | References1. ^Hofmann A. Psychotomimetic Drugs: Chemical and Pharmacological Aspects. Acta. Physiol. Pharmacol. Neerlandica. 1959;8:240-258. 2. ^{{ cite patent | country = US | number = 2997470 | status = patent | title = LYSERGIC ACID AMIDES | pubdate = 1956-03-05 | gdate = 1961-08-22 | inventor = Richard P. Pioch}} 3. ^David E. Nichols. LSD and Its Lysergamide Cousins. The Heffter Review of Psychedelic Research. 2001;2:80-87.
{{Hallucinogens}}{{Navboxes | title = Pharmacodynamics | titlestyle = background:#ccccff | list1 ={{Adrenergic receptor modulators}}{{Dopamine receptor modulators}}{{Serotonin receptor modulators}}{{TAAR ligands}} }}{{Ergolines}} 1 : Lysergamides |